Case File
efta-02672445DOJ Data Set 11OtherEFTA02672445
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02672445
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Tazia Smith
Sent:
Thursday, Octo er
,
:
To:
jeffrey epstein
Subject:
Re: FB (fyi).. [C]
Classification: Confidential
Understood
Tazia Smith
Director
Markets Coverage Group
Deutscheºnk Securities, Inc.
Deutsche Asset & Wealth Mana • ement
From: Jeffrey Epstein [î[email protected]]
Sent: 10/31/2013 12:02 PM AST
Tazia Smith
Subject: Re: FB (fyi).. [C] lets relook at next week
On Thu, Oct 31, 2013 at 11:59 AM, Taz=a Smith <[email protected] <mailto:[email protected]> wrote:
Classification: Co=fidential
Jeffrey -
FB trading `$50.70
You may have decided it's not worth selling the potential upside, but OTM calls FYI:
EFTA_R1_01945765
EFTA02672445
Jan 57.50 calls - 51.85
Jan 60 calls —$1.30
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communication<=r> in error) please notify the sender
immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the<=r> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this communÊtion is confidential, may be attorney-client privileged, may
constitute inside i=formation, and is intended only for the use of the addressee. It is the=property of
Jeffrey Epstein
Unauthorized use, disclosure or copying=of this communication or any part thereof is strictly prohibited
and may be unla=ful. If you have received this communication in error, please notify us=immediately by
return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and
destroy this communication and all copies thereof, including all attachm=nts. copyright -all rights reserved
2
EFTA_R1_01945766
EFTA02672446
This communication may contain confid=ntial and/or privileged information.
If you are not the intended recipient (or have received this communication<=r> in error) please notify the sender
immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the<=r> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
3
EFTA_R1_01945767
EFTA02672447
Technical Artifacts (7)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Email
[email protected]Email
[email protected]Phone
2672445Phone
2672446Phone
2672447Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.